Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.

Autor:	Keiichi Fujiwara1 fujiwara@saitama-med.ac.jp, Hiroyuki Fujiwara2, Hiroyuki Yoshida1, Toyomi Satoh3, Kan Yonemori4, Shoji Nagao5, Takashi Matsumoto6, Hiroaki Kobayashi7, Bourgeois, Hughes8, Harter, Philipp9, Mosconi, Anna Maria10, Vazquez, Isabel Palacio11, Reinthaller, Alexander12, Tomoko Fujita13, Rowe, Philip14, Pujade-Lauraine, Eric15, Ray-Coquard, Isabelle16
Zdroj:	Journal of Gynecologic Oncology. Sep2021, Vol. 32 Issue 5, p1-11. 11p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu